Cytokeratin 13 Antikörper
(1 reference)-
- Target Alle Cytokeratin 13 (KRT13) Antikörper anzeigen
- Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Cytokeratin 13 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- Goat polyclonal antibody raised against synthetic peptide of KRT13.
- Sequenz
- C-TSNASGRRTS DVRRP
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Synthetic Peptide.
- Immunogen
- A synthetic peptide corresponding to human KRT13.
- Top Product
- Discover our top product KRT13 Primärantikörper
-
anti-Keratin 13 (KRT13) (N-Term) antibody
KRT13 Reaktivität: Ratte, Maus IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 13 (KRT13) (C-Term) antibodyKRT13 Reaktivität: Ratte, Maus IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 13 (KRT13) (AA 104-403) antibodyKRT13 Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 13 (KRT13) (AA 104-458) antibodyKRT13 Reaktivität: Human WB, IHC, ELISA, FACS Wirt: Maus Monoclonal 7D7B3 unconjugated
anti-Keratin 13 (KRT13) antibodyKRT13 Reaktivität: Human WB, IHC (p), IF, ICC, IHC (wm) Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 13 (KRT13) (AA 143-295) antibodyKRT13 Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 3G4 unconjugated
anti-Keratin 13 (KRT13) (AA 269-458) antibodyKRT13 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Keratin 13 (KRT13) antibodyKRT13 Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Monoclonal unconjugated
anti-Keratin 13 (KRT13) antibodyKRT13 Reaktivität: Human, Ratte, Maus WB, IHC (p), IF (cc) Wirt: Kaninchen Monoclonal 5A3 unconjugated
anti-Keratin 13 (KRT13) antibodyKRT13 Reaktivität: Human IHC, IF, StM Wirt: Maus Monoclonal KRT13-2213 unconjugated
-
- Applikationshinweise
-
ELISA (1:128000)
Western Blot (0.1-0.3 μg/mL)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2-4 μg/mL)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
Store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
: "Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation." in: The Journal of biological chemistry, Vol. 282, Issue 34, pp. 24858-65, (2007) (PubMed).
-
: "Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation." in: The Journal of biological chemistry, Vol. 282, Issue 34, pp. 24858-65, (2007) (PubMed).
-
- Target
- Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))
- Andere Bezeichnung
- Cytokeratin 13 (KRT13 Produkte)
- Synonyme
- krt13 antikoerper, CK13 antikoerper, K13 antikoerper, Ka13 antikoerper, Krt-1.13 antikoerper, Krt1-13 antikoerper, ck13 antikoerper, k13 antikoerper, keratin 24 antikoerper, keratin 13 antikoerper, keratin 13, type I S homeolog antikoerper, krt24 antikoerper, KRT13 antikoerper, Krt13 antikoerper, krt13.S antikoerper, k13 antikoerper
- Gen-ID
- 3860
-
